Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lukoil may receive about $ 4.3 billion for the sale of its assets in Bulgaria

1/10/25 LKOH

Republika Srpska is committed to long-term relations with Gazprom

1/10/25 GAZP

Sovcombank prepares additional issue

1/10/25 SVCB

Cherkizovo poultry farm buildings on fire in Kursk region

1/9/25 GCHE

VTB completes rebranding of Otkritie branches

1/9/25 VTBR

Shareholders of Perm Energy Supply Company approved dividends

1/9/25 PMSB

Shareholders of Zaymer approved dividends

1/9/25 ZAYM

Inter RAO acquired Mezhregionenergoservice

1/9/25 IRAO

PIK may completely withdraw from the project near the Tretyakov Gallery

1/9/25 PIKK

Segezha Group shareholders approved the additional share issue

12/28/24 SGZH